These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711 [TBL] [Abstract][Full Text] [Related]
16. Islet transplantation in Type-I diabetes: current state and prospects. Mandel TE Ann Acad Med Singap; 1991 Jul; 20(4):513-8. PubMed ID: 1799266 [TBL] [Abstract][Full Text] [Related]
18. [Xenotransplantation of islets of Langerhans: a possible therapy for diabetes mellitus?]. Igaz P Wien Med Wochenschr; 2001; 151(13-14):291-4. PubMed ID: 11582992 [TBL] [Abstract][Full Text] [Related]
19. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms. Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665 [TBL] [Abstract][Full Text] [Related]
20. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Posselt AM; Szot GL; Frassetto LA; Masharani U; Tavakol M; Amin R; McElroy J; Ramos MD; Kerlan RK; Fong L; Vincenti F; Bluestone JA; Stock PG Transplantation; 2010 Dec; 90(12):1595-601. PubMed ID: 20978464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]